Previous Close | 22.75 |
Open | 22.66 |
Bid | 23.15 x 800 |
Ask | 24.17 x 800 |
Day's Range | 22.56 - 23.34 |
52 Week Range | 10.02 - 28.77 |
Volume | |
Avg. Volume | 384,619 |
Market Cap | 871.596M |
Beta (5Y Monthly) | 1.27 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.02 |
Earnings Date | Mar 04, 2024 - Mar 08, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 32.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for QTRX
Does Quanterix Corporation (QTRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
The mean of analysts' price targets for Quanterix Corporation (QTRX) points to a 33.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
BILLERICA, Mass., November 13, 2023--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue will speak in a fireside chat at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 16, 2023 at 3:00 PM ET. To access the live webcast, please register here. A replay will be available following the conference on Quante